KR900000482A - Bu-3420t 항종양 항생제 - Google Patents

Bu-3420t 항종양 항생제 Download PDF

Info

Publication number
KR900000482A
KR900000482A KR1019890007988A KR890007988A KR900000482A KR 900000482 A KR900000482 A KR 900000482A KR 1019890007988 A KR1019890007988 A KR 1019890007988A KR 890007988 A KR890007988 A KR 890007988A KR 900000482 A KR900000482 A KR 900000482A
Authority
KR
South Korea
Prior art keywords
triacetate
animal host
diluent
administering
host infected
Prior art date
Application number
KR1019890007988A
Other languages
English (en)
Other versions
KR910005631B1 (ko
Inventor
오꾸마 히로아끼
고니시 마사다까
마쓰모또 기요시
오끼 도시까즈
호시노 유따까
Original Assignee
아이삭 자아코브스키
브리스톨-마이어즈 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이삭 자아코브스키, 브리스톨-마이어즈 컴페니 filed Critical 아이삭 자아코브스키
Publication of KR900000482A publication Critical patent/KR900000482A/ko
Application granted granted Critical
Publication of KR910005631B1 publication Critical patent/KR910005631B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/29—Micromonospora
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/867—Micromonospora

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

BU-3420T 항종양 항생제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 BU-3420T의 적외선 흡수 스펙트럼을 나타낸 도면임(KBr중).
제2도는 DMSO-d6중의 트리아세틸 BU-3420T의 양성자 자기공명 스펙트럼(400MHz)를 나타낸 도면임.

Claims (12)

  1. 다음 구조식을 갖는 화합물 BU-3420T
  2. 다음의 일반식을 갖는 화합물 BU-3420T 트리아세테이트
    상기식중 R은 CH3CO-이다.
  3. 침수된 호기성 조건하에서 자화성 탄소원과 질소원이 함유된 수성 영양 배지중에서 BU-3420T-생산균주Micromonosporasp.nov가 실제량의 BU-3420T를 생산할때까지 상기 균주를 상기 배지중에서 배양시킨다음 배지로부터 상기 BU-3420T를 회수하는 단계를 포함함을 특징으로 하는 다음의 구조식을 갖는 BU-3420T의 제조방법.
  4. 제3항에 있어서, BU-3420T-생산균주가Micromonospora chersinaATCC 53710이거나 또는 그의 변종 또는 변이주인 것이 특징인 BU-3420T의 제조방법.
  5. 침수된 호기성 조건하에서 자화성 탄소 및 질소원을 함유하는 배양 배지에서 배양시켰을 때 회수가능한 양의 항생물질 BU-3420T를 생산할 수 있는 미생물Micromonospora chersinasp.nov.(ATCC 53710)의 생물학적으로 순수한 배양체.
  6. 다음의 구조식을 갖는 BU-3420T를 불활성 유기용매 중에서
    BU-3420T의 10, 12 및 15 위치에 아세틸기를 도입시킬 수 있는 아세틸화제와 반응시키는 단계를 포함함을 특징으로 하는 다음의 구조식을 갖는 BU-3420T트리아세테이트의 제조방법.
  7. 항세균 유효량 BU-3420T 또는 BU-3420T 트리아세테이트와 약리적으로 허용되는 불활성 담체 또는 희석제를 포함하는 약리적 조성물.
  8. 향진균 유효량의 BU-3420T 또는 BU-3420T 트리아세테이트와 약리적으로 허용되는 불활성 담체 또는 희석제를 포함하는 약리적 조성물.
  9. 종양 억제 유효량의 BU-3420T 또는 BU-3420T 트리아세테이트와 약리적으로 허용되는 불활성 담체 또는 희석제를 포함하는 약리적 조성물.
  10. 세균에 감염된 동물 숙주에게 BU-3420T나 또는 BU-3420T 트리아세테이트의 항세균 유효 투여량을 투여하는 것을 포함하는 세균에 감염된 동물숙주의 치료방법.
  11. 진균에 감염된 동물 숙주에게 BU-3420T나 또는 BU-3420T 트리아세테이트의 항진균 유효 투여량을 투여하는 것을 포함하는 진균에 감염된 동물 숙주의 치료방법.
  12. 악성 종양이 있는 포유류 숙주에게 BU-3420T나 또는 BU-3420T 트리아세테이트의 종양 억제 투여량을 투여하는 것을 포함하는 포유류의 악성 종양의 발육을 억제하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890007988A 1988-06-10 1989-06-09 Bu-3420t 항종양 항생제 KR910005631B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US208,330 1988-06-10
US208330 1988-06-10
US07/208,330 US4916065A (en) 1988-06-10 1988-06-10 BU-3420T Antitumor antibiotic

Publications (2)

Publication Number Publication Date
KR900000482A true KR900000482A (ko) 1990-01-30
KR910005631B1 KR910005631B1 (ko) 1991-08-01

Family

ID=22774189

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890007988A KR910005631B1 (ko) 1988-06-10 1989-06-09 Bu-3420t 항종양 항생제

Country Status (15)

Country Link
US (1) US4916065A (ko)
EP (1) EP0350623A3 (ko)
JP (1) JPH02117676A (ko)
KR (1) KR910005631B1 (ko)
AU (1) AU633826B2 (ko)
DK (1) DK283489A (ko)
FI (1) FI892788A (ko)
HU (3) HU205932B (ko)
IL (1) IL90548A (ko)
MY (1) MY104032A (ko)
NO (1) NO892328L (ko)
NZ (1) NZ229460A (ko)
PT (1) PT90806B (ko)
YU (1) YU46768B (ko)
ZA (1) ZA894393B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098708A (en) * 1990-06-14 1992-03-24 Bristol-Myers Squibb Company Antiviral antibiotic BU-3889V
KR910002457A (ko) * 1989-07-10 1991-02-25 원본미기재 항 비루스 항생제 bu-3889v
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US5066585A (en) * 1990-07-09 1991-11-19 Board Of Trustees Operating Michigan State University Method of inhibiting fungus using novel antifungal compounds
IE66159B1 (en) * 1990-08-01 1995-12-13 Scripps Research Inst Dynemicin analogs: synthesis methods of preparation and use
WO1992002522A1 (en) * 1990-08-01 1992-02-20 Scripps Clinic And Research Foundation Dynemicin analogs: syntheses, methods of preparation and use
US5162330A (en) * 1990-11-05 1992-11-10 Bristol-Myers Squibb Co. Dynemicin c antibiotic, its triacetyl derivative and pharmaceutical composition containing same
WO1996003124A1 (en) * 1994-07-27 1996-02-08 California Institute Of Technology Dynemicin analogs
WO2003062458A2 (en) * 2002-01-24 2003-07-31 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
US4675187A (en) * 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4594248A (en) * 1985-03-15 1986-06-10 Warner-Lambert Company CL-1577-B4 compound, its production and use
IL79519A0 (en) * 1985-08-27 1986-10-31 Bristol Myers Co Bbm-1675c and d antitumor antibiotics

Also Published As

Publication number Publication date
FI892788A (fi) 1989-12-11
YU118589A (en) 1991-04-30
DK283489D0 (da) 1989-06-09
NO892328D0 (no) 1989-06-07
AU633826B2 (en) 1993-02-11
HU205932B (en) 1992-07-28
YU46768B (sh) 1994-05-10
FI892788A0 (fi) 1989-06-07
NZ229460A (en) 1992-02-25
PT90806A (pt) 1989-12-29
HUT52163A (en) 1990-06-28
HUT57774A (en) 1991-12-30
EP0350623A3 (en) 1991-07-03
HU202591B (en) 1991-03-28
ZA894393B (en) 1990-09-26
EP0350623A2 (en) 1990-01-17
DK283489A (da) 1989-12-11
IL90548A0 (en) 1990-01-18
NO892328L (no) 1989-12-11
KR910005631B1 (ko) 1991-08-01
HU901778D0 (en) 1990-06-28
AU3633889A (en) 1989-12-21
JPH02117676A (ja) 1990-05-02
IL90548A (en) 1994-01-25
MY104032A (en) 1993-10-30
PT90806B (pt) 1994-10-31
US4916065A (en) 1990-04-10

Similar Documents

Publication Publication Date Title
KR900008049A (ko) Bu-3608 항생제의 세린 동족체
KR900000482A (ko) Bu-3420t 항종양 항생제
KR840007257A (ko) 레베카마이신과 그것의 제조방법
GB1083662A (en) A novel antibiotic, methods for its production and therapeutic compositions containing it
KR840005483A (ko) A47934 항생물질의 제조방법
KR890002214A (ko) 데만노실 테이코플라닌 유도체
ES373632A1 (es) Procedimiento para la preparacion de la donorubicina por cultivo de un streptomyces.
GB1314657A (en) Antibiotics
KR920009986A (ko) 다이네마이신 c 항종양 항생제
ES8700316A1 (es) Un procedimiento para la preparacion de compuesto denominado cl-1724b-2
ES395935A1 (es) Un procedimiento para la produccion del antibiotico de ws- 4.545.
KR840004442A (ko) 란카시딘의 개량 제조방법
US4423218A (en) Antibiotic neplanocin A
KR840008817A (ko) Bbm-1675, 새로운 항암 항생복합체
KR890014457A (ko) 신규 아족시 화합물 및 그의 제조방법
JPS5648893A (en) Preparation of anthracycline glycoside
KR890014102A (ko) Bu-3862t 항종양 항생제
KR910002457A (ko) 항 비루스 항생제 bu-3889v
KR910014509A (ko) 항생성 알리사마이신, 이의 제조방법 및 용도
KR910006314A (ko) 항생물질 LL-E19020 α 및 β의 화학적 유도체, 그를 투여하여 세균감염을 치료하는 방법 및 그를 포함한 제약학적 조성물
ES354475A1 (es) Mejoras introducidas en un antibiotico.
KR930006041A (ko) 화합물 ll-e19020 알파₁, 그의 생산방법, 및 그를 포함하는 제약학적 항생물질 조성물
KR920002497A (ko) 스테롤 화합물
KR920021571A (ko) 3'및/또는 4'oh기에서 엘사마이신 a의 화학적 변형
ES485529A1 (es) Un procedimiento para la produccion de ravidomicina

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee